Advanced search
Publication Cover
Medical Mycology Volume 49, 2011 - Issue 2
Submit an article Journal homepage
53
Views
2
CrossRef citations to date
0
Altmetric
Case Reports

Intracavitary voriconazole for the treatment of hemoptysis complicating Pseudallescheria angusta pulmonary mycetomas in fibrocystic sarcoidosis

Jared N. Kravitz *Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
,
Lisa L. Steed Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
&
Marc A. Judson *Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina, USACorrespondence[email protected]
Pages 198-201 | Received 04 May 2010, Accepted 29 Jul 2010, Published online: 10 Sep 2010

References

  • Wollschlager C, Khan F. Aspergillomas complicating sarcoidosis: a current perspective. Chest 1984; 86: 585–588.
  • Jewkes J, Kay PH, Paneth M, Citron KM. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 1983; 38: 572–578.
  • Gilgado F, Cano J, Gené J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol 2005; 43: 4930–4942.
  • Chaudhary BA, McAlexander D, el Gammal T, Speir WA. Multiple mycetomas due to Pseudallescheria boydii. South Med J 1987; 80: 653–654.
  • Belitsos NJ, Merz WG, Bowersox DW, Hutchins GM. Allescheria boydii mycetoma complicating pulmonary sarcoid. Johns Hopkins Med J 1974; 135: 259–267.
  • Judson MA. Noninvasive Aspergillus pulmonary disease. Sem Respir Crit Care Med 2004; 25: 203–219.
  • Gilgado F, Serena C, Cano J, Gené J, Guarro J. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother 2006; 50: 4211–4213.
  • Cortez KJ, Roilides E, Quiroz-Telles F, . Infections caused by Scedosporium spp. Clin Microbiol Rev 2008; 21: 157–197.
  • Panackal AA, Marr KA. Scedosporium/Pseudallescheria infections. Sem Respir Crit Care Med 2004; 25: 171–181.
  • Gilgado F, Cano J, Gené J, Sutton DA, Guarro J. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol 2008; 46: 766–771.
  • Riscili BP, Wood KL. Noninvasive pulmonary Aspergillus infections. Clin Chest Medicine 2009; 30: 315–335.
  • Tomlinson JR, Sahn SA. Aspergilloma in sarcoid and tuberculosis. Chest 1987; 92: 505–508.
  • Israel HL, Lenchner GS, Atkinson GW. Sarcoidosis and aspergilloma. The role of surgery. Chest 1982; 82: 430–432.
  • Walsh TJ, Anaissie EJ, Denning DW, . Treatment of aspergillosis: clinical practice guidelines of the Infectious Disease Society of America. Clin Infect Dis 2008; 46: 327–360.
  • Campbell JH, Winter JH, Richardson MD, Shankland GS, Banham SW. Treatment of pulmonary aspergilloma with itraconazole. Thorax 1991; 46: 839–841.
  • Krakówka P, Traczyk K, Walczak J, . Local treatment of aspergilloma of the lung with a paste containing nystatin or amphotericin B. Tubercle 1970; 51: 184–191.
  • Giron J, Poey C, Fajadet P, . CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 cases. Eur J Radiol 1998; 28: 235–242.
  • Lee KS, Kim HT, Kim YH, Choe KO. Treatment of hemoptysis in patients with cavitary aspergilloma of the lung: value of percutaneous instillation of amphotericin B. AJR Am J Roentgenol 1993; 161: 727–731.
  • Shapiro MJ, Albelda SM, Mayock RL, McLean GK. Severe hemoptysis associated with pulmonary aspergilloma. Percutaneous intracavitary treatment. Chest 1988; 94: 1225–1231.
  • Meletiadis J, Meis JF, Mouton JW, . In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother 2002; 46: 62–68.
  • Perfect JR, Marr KA, Walsh TJ, . Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003; 36: 1122–1131.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.